Summer 1997 NBER Workshop on "Intellectual Property in Pharmaceuticals and Biotechnology"

9:00 - 9:10 a.m.

Welcome

Josh Lerner, Harvard Business School

Part I: Patent Policy Reform and the Pharmaceutical Industry

9:10 - 9:45 a.m.

"Intellectual Property and the Location of Innovative Activity: The Canadian Experience with the Compulsory Licensing of Pharmaceutical Patents," Donald McFetridge, Carleton University

9:45 - 10:20 a.m.

"The Introduction of Pharmaceutical Product Patents in India: ‘Heartless Exploitation of the Poor and Suffering’?," Jean O. Lanjouw, Yale University

10:20 - 10:35 a.m.

Break

10:35 - 11:15 a.m.

Discussion of Lanjouw and McFetridge Papers, F.M. Scherer, Kennedy School of Government, Harvard University

Part II: Innovation and the Structure of Intellectual Property Protection

11:15 a.m. - 12:20 p.m.

"Upstream Patents and Downstream Products: A Tragedy of the Anticommons?," Rebecca S. Eisenberg and Michael A. Heller, University of Michigan School of Law

Discussant: Iain Cockburn, University of British Columbia

12:20-1:25 p.m.

Lunch

1:25 - 2:30 p.m.

"Alternative Intellectual Property Protection Systems for Trade in International Plant Genetic Resources," Brian D. Wright and Bonwoo Koo, University of California—Berkeley

Discussant: R. David Simpson, Resources for the Future

2:30- 2:45 p.m.

Break

Part III: Intellectual Property and the Future of the Pharmaceutical and Biotech Industries

2:45 - 4:15 p.m.

Panel Discussants:

• Robert P. Blackburn, Vice President and Chief Patent Counsel, Chiron Corporation
• Lynn H. Pasahow, Partner, McCutchen, Doyle, Brown & Enersen
• John W. Schlicher, Fish & Neave, and Lecturer, Stanford Law School
• Dr. Bennett M. Shapiro, Executive Vice President, Merck Worldwide Basic Research